Science

Scientific excellence is an important pillar for Oncode Institute and we are proud of the outstanding researchers that are part of Oncode. Below is an overview of the scientific progress of 2019.

Supporting state-of-the-art facilities for our community

The objective of our Infrastructure & Technologies (I&T) Programme is to support the Oncode research community with access to state-of-the-art research facilities. The programme specifically targets larger equipment and infrastructure projects that are more cost-effective when shared by more than one research group or institute.

Read more...

Our publications: a few highlights

In 2019, a total of 463 peer-reviewed papers were published by Oncode Researchers. Of these, 72 were written in collaboration with industrial partners and 70% were published in open access journals. Highlights of these papers are listed below.

Read more...


Base funds to fuel breakthrough discoveries

Oncode strives to create an environment in which Oncode researchers can reach their maximum innovation potential. To that end, we use our base fund to enable each of our investigators to pursue innovative research in uncharted areas of cancer biology.

Read more...

The Oncode Training Programme

The Oncode Training Programme provides our researchers with tailored training to help them with the use of research tools, as well as extending their network. In 2019, Oncode organized four science-driven technical masterclasses that were co-created with Oncode Investigators and researchers.

Read more...

From fundamental science to the clinic

Oncode brings basic research and clinical practice closer together to enable the effective translation of promising research into novel clinical treatment strategies. To support this goal, Oncode created its Clinical Proof-of-Concept (CPoC) Programme, with an earmarked budget of €10M for pre-clinical and early clinical studies based on findings from Oncode research labs.

Read more...

At a glance

Outsmarting cancer

impacting lives

Science in person

Outsmarting cancer

impacting lives